Abbott India net profit up 1 percent to Rs 181 crore in Q2
Advertisement
New Delhi: Drug maker Abbott India on Wednesday reported a 1.34 percent increase in net profit at Rs 180.73 crore for the second quarter ended September 30. The company had posted a net profit of Rs 178.33 crore in July-September quarter of previous fiscal.
Revenue from operations remained flat at Rs 1,054.85 crore during the quarter under review as compared with Rs 1,054.80 crore in the year-ago period, Abbott India said in a regulatory filing.
The extended lockdown on account of Covid-19 has led to a slowdown in demand in some therapeutic areas and resulted in lower sales, it added.
The company continues to closely monitor the situation and will take appropriate measures in an attempt to mitigate any adverse impact, it said.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.